• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD PERIPHERAL VASCULAR, INC. SENOMARK ULTRA MARKER; BREAST TISSUE MARKER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD PERIPHERAL VASCULAR, INC. SENOMARK ULTRA MARKER; BREAST TISSUE MARKER Back to Search Results
Catalog Number SMEC10R
Device Problem Device Contamination with Chemical or Other Material (2944)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 01/31/2017
Event Type  malfunction  
Manufacturer Narrative
No medical records or no medical images have been made available to the manufacturer.The device has not been returned to the manufacturer for evaluation, however the material found has been returned.As the lot number for the device was not provided, a review of the device history records was unable to be performed.The investigation of the reported event is currently underway.The information provided by bard represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bard.
 
Event Description
It was reported that after completing breast tissue marker placement, there was allegedly foreign white material found on the tip of the probe.There was no reported patient injury.
 
Manufacturer Narrative
Manufacturing review: a full manufacturing review could not be conducted as the lot number is unknown.It is unknown if manufacturing contributed to the reported event.Visual inspection: the pellet was returned in a sample pouch, sealed by the user.The pellet was removed from the pouch and inspected under magnification.The pellet was measured and found to be approximately 0.105" in length, and 0.0469" in diameter.These dimensions do not meet the criteria for the peg pellet.However these measurements are not considered accurate dimensions of a finished pellet as handling of the material would have altered the dimensions of the device, as indicated by the rounded appearance of the material edges.Functional/performance evaluation: functional testing was not applicable, due to the nature of the complaint.The unidentified material was analyzed via ftir spectroscopy.The results indicated that the returned material was matched with 99.62 percent confidence to a senomark ultra peg pellet.Medical records review:medical records were not provided; therefore, a review could not be performed.Image/photo review: image/photo was not provided; therefore, a review could not be performed.Conclusion:the investigation is unconfirmed for the reported foreign material, as the returned material was found to be a peg push pellet, which is not foreign to the returned device.It was determined that the returned material that was reported to be at the tip of the deployed device, was found to be the device peg pellet, which is not considered foreign material.Labeling review:the current senomark ultra breast biopsy marker instructions for use (ifu) states: the senomark® ultra breast tissue marker consists of a disposable applicator containing: - 3 resorbable polyglycolic acid (pga) pads that are essentially resorbed in approximately 12 weeks.The center pad contains a titanium or biodur¿ 108 wireform with an interwoven polyvinyl alcohol (pva) polymer for permanent ultrasound enhancement.Please note the (pva) polymer is not resorbed.- 1 polyethylene glycol (peg) push pellet.Precautions: - this product should only be used by a physician who is completely familiar with the indications, contraindications, limitations, typical findings and possible side effects of breast tissue marker placement.Complications: - complications may occur at any time during or after the procedure.Potential complications of breast tissue marker placement may include, but are not limited to: hematoma, hemorrhage, infection, adjacent tissue injury and pain.How supplied.- the senomark® ultra breast tissue marker is provided sterile and non-pyrogenic unless the package has been opened or damaged.Sterilized by using irradiation.For single use only.Do not reuse.Do not resterilize.(b)(4).The information provided by bard represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bard.
 
Event Description
It was reported that after completing breast tissue marker placement, there was allegedly foreign white material found on the tip of the probe.There was no reported patient injury.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SENOMARK ULTRA MARKER
Type of Device
BREAST TISSUE MARKER
Manufacturer (Section D)
BARD PERIPHERAL VASCULAR, INC.
1625 w 3rd st.
tempe AZ 85281
Manufacturer (Section G)
INFUS MEDICAL (THAILAND)
706 moo 4
bangpoo ind estate
samutprakarn province 10280
TH   10280
Manufacturer Contact
judith ludwig
1625 w 3rd st.
tempe, AZ 85281
4803032689
MDR Report Key6362360
MDR Text Key68471632
Report Number2020394-2017-00114
Device Sequence Number1
Product Code NEU
UDI-Device Identifier00801741032035
UDI-Public(01)00801741032035
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K123911
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 04/17/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/27/2017
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberSMEC10R
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/22/2017
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/03/2017
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-